Total numbers approached 1010 (g wet wt)-1, while numbers capable of growing on sugar-free media after 7 d were about 108 (g wet wt)-1. Actual counts on Trypticase medium varied from 0.8 × 107 to 3.5 × 108 (g wet wt)-1. Monensin decreased numbers in Trypticase medium by an average of 92% to 105-106 (g wet wt)-1. Amino acid utilizers were on average only slightly (26%) fewer in number than Trypticase utilizers. Figure 1 Most-probable-numbers (MPN) counts of Trypticase

and amino acid-utilising bacteria in faeces from human omnivorous (O2 and O3) and vegetarian (V1 and V2) donors. Results are from 7-d counts. Error bars represent 95% confidence levels. Bacterial isolates A total of 53 isolates was isolated Mizoribine supplier from the highest dilutions of faecal bacteria from two ominivores and one vegetarian. Twenty-eight survived repeated sub-culture, of which 24 gave full length or near full length 16S rRNA gene sequences (Table 3). The remaining four were identified from partial sequences. None of the isolates was asaccharolytic, growth being increased significantly in all cases by the addition of glucose to the medium. The bacteria enriched from the faecal samples appeared

to be different depending on whether the substrate was peptides or amino acids. Shigella spp. and E. coli were more numerous in the amino acids-containing cultures. Other pathogens that were enriched included Enterococcus faecalis, Staphylococcus sp. and Eggerthella lenta. Table 3 Identity of bacteria isolated from peptides or amino acids enrichments Isolate Vol/ diln Identification % Sim Phylum Class Order Accession no. Peptides             1 O1/5 Clostridium this website perfringens 99 Firmicutes Clostridia Clostridiales GU968162 3 O1/5 Clostridium orbiscindens 99 Firmicutes Clostridia Clostridiales GU968163 5 O1/5 Shigella sonnei 98 Proteobacteria Gammaproteobacteria Enterobacteriales GU968164 6 O1/6 Enterococcus faecium 99 Firmicutes Bacilli Lactobacillales GU968165 8 O1/6 Bacteroides ovatus 99 Bacteroidetes Montelukast Sodium Bacteroidia

Bacteroidales GU968166 12 O2/5 C. orbiscindens 97 Firmicutes Clostridia Clostridiales 893 bp 13 O2/5 Clostridium innocuum 98 Firmicutes Clostridia Clostridiales GU968167 14 O2/5 B. ovatus 93 Bacteroidetes Bacteroidia Bacteroidales GU968168 15 O2/5 Blautia hydrogenotrophica 95 Firmicutes Clostridia Clostridiales GU968169 16 O2/6 C. orbiscindens 95 Firmicutes Clostridia Clostridiales 877 bp 17 O2/6 C. orbiscindens 99 Firmicutes Clostridia Clostridiales GU968170 21 V1/5 Bacteroides fragilis 99 Bacteroidetes Bacteroidia Bacteroidales GU968171 22 V1/5 Escherichia coli 99 Proteobacteria Gammaproteobacteria Enterobacteriales GU968172 23 V1/5 B. fragilis 98 Bacteroidetes Bacteroidia Bacteroidales GU968173 25 V1/6 B. fragilis 99 Bacteroidetes Bacteroidia Bacteroidales GU968174 27 V1/6 E. faecium 99 Firmicutes Bacilli Lactobacillales Salubrinal cost GU968175 Amino acids             29 O1/6 Shigella sp.

Cancer Cell 2007,11(1):37–51.PubMedCrossRef 38. Diehn MCR, Lobo NA, selleck kinase inhibitor Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M,

Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, Clarke MF: Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009,458(7239):780–783.PubMedCrossRef 39. Brabec V, Nováková O: DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity. Drug Resistance Updates 2006,9(3):111–122.PubMedCrossRef 40. Yu H, Zhou Y, Lind SE, Ding WQ: Clioquinol targets zinc to lysosomes in human cancer cells. Biochem J 2009,417(1):133–139.PubMedCrossRef 41. Efferth T: Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy. Drug Resistance Updates 2005,8(1–2):85–97.PubMedCrossRef 42. Moore JCLH, Li JR, Ren RL, McDougall JA, Singh NP, Chou CK: Oral selleck administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat. Cancer learn more Lett 1995,98(1):83–87.PubMed 43. Brown JM, Giaccia AJ: The Unique Physiology of Solid Tumors: Opportunities (and Problems) for Cancer Therapy. Cancer Research 1998,58(7):1408–1416.PubMed 44. Höckel MVP: Biological consequences of tumor hypoxia. Semin Oncol 2001,28(2 Suppl 8):36–41.PubMedCrossRef 45. Harris AL: Hypoxia [mdash] a key regulatory Non-specific serine/threonine protein kinase factor

in tumour growth. Nat Rev Cancer 2002,2(1):38–47.PubMedCrossRef 46. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003,3(10):721–732.PubMedCrossRef 47. Sowter HMRR, Moore JW, Ratcliffe PJ, Harris AL: Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res 2003,63(19):6130–6134.PubMed 48. Eckard JDJ, Wu J, Jian J, Yang Q, Chen H, Costa M, Frenkel K, Huang X: Effects of cellular iron deficiency on the formation

of vascular endothelial growth factor and angiogenesis. Iron deficiency and angiogenesis. Cancer Cell Int 2010.,10(28): Competing interests The authors declare that they have no competing interests. Authors’ contributions ZL developed the screening techniques, designed and performed most of the experiments and drafted the manuscript. HT performed and analysed part of the screening validation experiments. FG engaged in data acquisition of primary screening. JG developed the strategy to screen for iron regulatory compounds and was involved in data analysis and manuscript revision. All authors read and approved the final manuscript.”
“Background Lung cancer is the leading cause of cancer-related death in the world, and non-small cell lung cancer accounts for approximately 80% of all cases[1, 2]. Despite advances in diagnostic and therapeutic, the overall 5-year survival rate in many countries is generally less than 15%[3].

The film grown on the Si substrate exhibited a polycrystalline structure. The surface morphology of the ZFO thin film substantially depended on its crystallographic features. The SEM and AFM images demonstrated that the surface of the ZFO (222) epitaxial film was flat and smooth; however, the surface of the randomly oriented film was rough and exhibited

3D grains. The visible emission bands of the ZFO thin films were attributed to growth-induced oxygen vacancies. The ZFO thin films demonstrated a spin-glass transition temperature of approximately 40 K. The ZFO (222) epitaxial film exhibited the most BMN 673 price marked Epigenetics inhibitor magnetic anisotropy among the samples. Acknowledgements This work is supported by the National Science Council of Taiwan (grant no.NSC 102-2221-E-019-006-MY3) and National Taiwan Ocean University (grant no. NTOU-RD-AA-2012-104012). The authors thank assistance in SEM examination given by the sophisticated instrument user center of National Taiwan Ocean University. References 1. Liu GG, URMC-099 purchase Zhang XZ, Xu YJ, Niu XS, Zheng LQ, Ding XJ: Effect of ZnFe 2 O 4 doping on the photocatalytic activity of TiO 2 . Chemosphere 2004, 55:1287–1291.CrossRef 2. Gudiksen MS, Lauhon LJ, Wang JF, Smith DC,

Lieber CM: Growth of nanowire superlattice structures for nanoscale photonics and electronics. Nature 2002, 415:617–620.CrossRef 3. Oliver SA, Hamdeh HH: Localized spin canting in partially inverted ZnFe 2 O 4 fine powders. Phys Rev B 1999, 60:3400–3405.CrossRef 4. Sun L, Shao R, Tang L, Chen Z: Synthesis of ZnFe 2 O 4 /ZnO nanocomposites immobilized on graphene with enhanced

photocatalytic activity under solar light irradiation. J Alloys Compounds 2013, 564:55–62.CrossRef 5. Liu H, Guo Y, Zhang Y, Wu F, Liu Y, Zhang D: Synthesis and properties of ZnFe 2 O 4 replica with Thymidine kinase biological hierarchical structure. Mater Sci Eng B 2013, 178:1057–1061.CrossRef 6. Chen CH, Liang YH, Zhang WD: ZnFe 2 O 4 /MWCNTs composite with enhanced photocatalytic activity under visible-light irradiation. J Alloys Compounds 2010, 501:168–172.CrossRef 7. Chen ZP, Fang WQ, Zhang B, Yang HG: High-yield synthesis and magnetic properties of ZnFe 2 O 4 single crystal nanocubes in aqueous solution. J Alloys Compounds 2013, 550:348–352.CrossRef 8. Tanaka K, Nakashima S, Fujita K, Hirao K: High magnetization and the Faraday effect for ferrimagnetic zinc ferrite thin film. J Phys Condens Matter 2003, 15:L469-L474.CrossRef 9. Yamamoto Y, Tanaka H, Kawai T: The control of cluster-glass transition temperature in Spinel-type ZnFe 2 O 4-δ thin film. Jpn J Appl Phys 2001, 40:L545-L547.CrossRef 10. Nakashima S, Fujita K, Tanaka K, Hirao K: High magnetization and the high-temperature superparamagnetic transition with intercluster interaction in disordered zinc ferrite thin film. J Phys Condens Matter 2005, 17:137.CrossRef 11.

1. While the mean value for d = 5 (Fig. 2c) is rather similar (33.3 ± 69.2), its range size check details frequency distribution has a higher skewness (4.5) and a higher maximum (831). Fig. 2 Range size frequency distributions for all species. a Range size frequency distributions of the point-to-grid data. b–e Range size frequency distributions for selected interpolation distances. f Distance-weighted range size frequency distributions. The y-axis extends to 3,800, including a gap for y-values between 320 and 3,100 H 89 datasheet species richness Although our original point-to-grid species richness map (Fig. 3a) contains more species than

the species richness map of a previous study (Morawetz and Raedig 2007) it identifies rather similar biodiversity centers. Point-to-grid species richness centers lie in Guatemala and adjacent regions, in Costa Rica and Panama reaching into the Chocó, in the Guyanas and at the border triangle of Venezuela, Colombia and Brazil. Moreover they stretch buy Doramapimod along the Andes (with peaks in the Ecuadorian and Peruvian Andes), along the Amazon with peaks close to Iquitos, Manaus, Santarém and Belém, and at the Brazilian Atlantic coast (Fig. 3a). The combination of the species richness grids over all distances according to Eq. 1 yields the map of weighted species richness (Fig. 3b) and results in four prominent species richness

centers: one in Central America (1), crossing into the Andean species richness center (2), one Amazonian center (3) and one center in coastal Brazil (4). The final species richness map (Fig. 3c) adjusts for sampling effort according to these centers of species richness. It turned out that the reference quadrats with the maximum number of species chosen for each of the four centers are all located close to cities and rivers, i.e. easily accessible and therefore related to higher sampling effort: the quadrat at Iquitos (Peru) for Amazonia, the quadrat north from San José (Costa Rica) for Central America, the quadrat at Cali (Colombia, Valle de Cauca) for the Andes, and the quadrat at Rio de Janeiro (Brazil) for the Mata Atlântica. Fig. 3

Species richness of Neotropical angiosperms per quadrat. a Point-to-grid species richness (maximum number of species per quadrat: 331). b Weighted species richness (maximum however number of species per quadrat: 391). c Species richness adjusted for sampling effort (maximum number of species per quadrat: 331) with delineation of the four largest species richness centers. 1—Central American, 2—Andean, 3—Amazonian, 4—Mata Atlântica species richness center. Projection: Aitoff, Central Meridian 60°W Transferring the outlines of these centers of species richness to the maps of point-to-grid (Fig. 3a) and adjusted species richness (Fig. 3c), the Amazonian point-to-grid center of species richness has the lowest mean value (50.7 ± 49.5 species per quadrat, Table 1), whereas the mean value for the Amazonian center of adjusted species richness is highest (143.5 ± 32.9).

Virology 2005,338(1):53–60.CrossRefInhibitor Library nmr PubMed 40. Charrin S, Manie S, Oualid M, Billard M, Boucheix C, Rubinstein E: Differential stability of tetraspanin/tetraspanin interactions: role of palmitoylation. FEBS Lett 2002,516(1–3):139–144.CrossRefPubMed 41. Han J, Hajjar DP, Tauras JM, Nicholson AC: Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36. J Lipid Res 1999,40(5):830–838.PubMed 42. Sun Y, Wang N, Tall AR: Regulation of adrenal scavenger receptor-BI Belnacasan supplier expression by ACTH and cellular cholesterol pools. J Lipid Res 1999,40(10):1799–1805.PubMed

43. Yu L, Cao G, Repa J, Stangl H: Sterol regulation of scavenger receptor class B type I in macrophages. J Lipid Res 2004,45(5):889–899.CrossRefPubMed 44. Lambert D, O’Neill CA, Padfield PJ: Depletion of Caco-2 cell cholesterol disrupts barrier function by altering the detergent solubility and distribution of specific tight-junction proteins. Biochem J 2005,387(Pt 2):553–560.PubMed 45. Lambert D, O’Neill CA, Padfield PJ: Methyl-beta-cyclodextrin increases permeability of Caco-2 cell monolayers by displacing specific claudins from cholesterol rich domains associated with tight junctions. Cell Physiol Biochem 2007,20(5):495–506.CrossRefPubMed 46. Bollinger CR, Teichgraber V, Gulbins E: Ceramide-enriched membrane domains. Selumetinib manufacturer Biochim Biophys Acta 2005,1746(3):284–294.CrossRefPubMed 47. Voisset

C, Lavie M, Helle F, Op De Beeck A, Bilheu A, Bertrand-Michel J, Terce F, Cocquerel L, Wychowski C, Vu-Dac N, et al.: selleck screening library Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry. Cell Microbiol 2008,10(3):606–617.CrossRefPubMed 48. Akazawa D, Date T, Morikawa K, Murayama A, Miyamoto M, Kaga M, Barth H, Baumert TF, Dubuisson J, Wakita T: CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. J Virol 2007,81(10):5036–5045.CrossRefPubMed 49. Tscherne DM, Evans MJ,

von Hahn T, Jones CT, Stamataki Z, McKeating JA, Lindenbach BD, Rice CM: Superinfection exclusion in cells infected with hepatitis C virus. J Virol 2007,81(8):3693–3703.CrossRefPubMed 50. Zhong J, Gastaminza P, Chung J, Stamataki Z, Isogawa M, Cheng G, McKeating JA, Chisari FV: Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J Virol 2006,80(22):11082–11093.CrossRefPubMed 51. Koutsoudakis G, Herrmann E, Kallis S, Bartenschlager R, Pietschmann T: The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J Virol 2007,81(2):588–598.CrossRefPubMed 52. Masciopinto F, Giovani C, Campagnoli S, Galli-Stampino L, Colombatto P, Brunetto M, Yen TS, Houghton M, Pileri P, Abrignani S: Association of hepatitis C virus envelope proteins with exosomes. Eur J Immunol 2004,34(10):2834–2842.CrossRefPubMed 53. Helle F, Dubuisson J: Hepatitis C virus entry into host cells. Cell Mol Life Sci 2008,65(1):100–112.CrossRefPubMed 54.

Warnick TA, Methe BA, Leschine SB: Clostridium phytofermentans sp. nov., a cellulolytic mesophile from forest soil. Int J Syst Evol Microbiol 2002,52(Pt 4):1155–1160.PubMedCrossRef 46. Islam R, Cicek N, Sparling R, Levin D: Effect of substrate loading on hydrogen TSA HDAC chemical structure production during anaerobic fermentation by Clostridium thermocellum 27405. Appl Microbiol

Biotechnol 2006,72(3):576–583.PubMedCrossRef 47. Freier D, Mothershed CP, Wiegel J: Characterization of Clostridium thermocellum JW20. Appl Environ Microbiol 1988,54(1):204–211.PubMed 48. Lacis LS, Lawford HG: Ethanol-production from xylose by thermoanaerobacter-ethanolicus in batch and continuous culture. Arch Microbiol 1988,150(1):48–55.CrossRef 49. Lacis LS, Lawford HG: Thermoanaerobacter ethanolicus growth

and product yield from elevated levels of xylose or glucose in continuous cultures. Appl Environ Microbiol 1991,57(2):579–585.PubMed 50. Wiegel J, Ljungdahl LG: Thermoanaerobacter ethanolicus gen. nov., spec. nov., a new, extreme thermophilic, anaerobic bacterium. Arch Microbiol 1981,128(4):343–348.CrossRef 51. Ouhib-Jacobs O, Lindley ND, Schmitt P, Clavel T: Fructose and glucose mediates enterotoxin production and anaerobic metabolism PXD101 purchase of Bacillus cereus ATCC14579(T). J Appl Microbiol 2009,107(3):821–829.PubMedCrossRef 52. Tang YJ, Sapra R, Joyner D, Hazen TC, Myers S, Reichmuth D, Blanch H, Keasling JD: Analysis of metabolic pathways and fluxes in http://www.selleck.co.jp/products/tenofovir-alafenamide-gs-7340.html a newly discovered thermophilic and ethanol-tolerant

Geobacillus strain. Biotechnol Bioeng 2009,102(5):1377–1386.PubMedCrossRef 53. Stevenson DM, Weimer PJ: Expression of 17 genes in Clostridium thermocellum ATCC 27405 during fermentation of selleck screening library cellulose or cellobiose in continuous culture. Appl Environ Microbiol 2005,71(8):4672–4678.PubMedCrossRef 54. Strobel HJ: Growth of the thermophilic bacterium Clostridium thermocellum in continuous culture. Curr Microbiol 1995,31(4):210–214.CrossRef 55. Guedon E, Payot S, Desvaux M, Petitdemange H: Carbon and electron flow in Clostridium cellulolyticum grown in chemostat culture on synthetic medium. J Bacteriol 1999,181(10):3262–3269.PubMed 56. Özkan M, Ylmaz E, Lynd LR, Özcengiz G: Cloning and expression of the Clostridium thermocellum L-lactate dehydrogenase in Escherichia coli and enzyme characterization. Can J Microbiol 2004, 50:845–851.PubMedCrossRef 57. Willquist K, Zeidan AA, van Niel EW: Physiological characteristics of the extreme thermophile Caldicellulosiruptor saccharolyticus: an efficient hydrogen cell factory. Microb Cell Fact 2010, 9:89.PubMedCrossRef 58. Desvaux M, Guedon E, Petitdemange H: Metabolic flux in cellulose batch and cellulose-fed continuous cultures of Clostridium cellulolyticum in response to acidic environment. Microbiology 2001,147(Pt 6):1461–1471.PubMed 59. Desvaux M, Petitdemange H: Flux analysis of the metabolism of Clostridium cellulolyticum grown in cellulose-fed continuous culture on a chemically defined medium under ammonium-limited conditions.

DOI 10.1007/s00421–011–2056–3 33. Strauss MB, Davis RK, Rosenbaum JD, Rossmeisl EC: Water diuresis produced during recumbency by the intravenous infusion of isotonic saline solution. J Clin Invest 1951, 30:862–868.PubMedCrossRef 34. Van Beaumont W: Evaluation of hemoconcentration from hematocrit measurements. J Appl Physiol 1972, 32:712–713.PubMed 35. Kirchhoff E: Online-publication of the German Food Composition Table ‘Souci-Fachmann-Kraut’ on the internet. J Food Comp Anal 2002, 15:465–472.CrossRef 36. Kavouras SA: Assessing hydration status. Curr Opin Clin Nutr Metab Care 2002, 5:519–524.PubMedCrossRef 37. Shirreffs SM: Markers of hydration status. Eur J Clin Nutr 2003, 57:S6-S9.PubMedCrossRef

38. Kratz A, Lewandrowski KB: Normal reference laboratory values. N Engl J Med 1998, 339:1063–1072.PubMedCrossRef 39. Rogers G, Goodman C, Rosen C: Water budget during ultra-endurance exercise. Med Sci Sports VRT752271 cell line Exerc 1997, 29:1477–1481.PubMedCrossRef 40. Speedy DB, Rogers IR, Noakes TD, Thompson JM, Guirey J, Safih S, Boswell DR: Diagnosis and prevention of hyponatremia at an ultradistance

triathlon. Clin J Sport Med 2000, 10:52–58.PubMedCrossRef 41. Hew-Butler T, Collins M, Bosch A, Sharwood K, Wilson G, Armstrong M, Jennings C, Swart J, Noakes T: Maintenance of plasma volume and serum sodium concentration despite body weight loss in ironman triathletes. Clin J Sport Med 2007, 17:116–122.PubMedCrossRef 42. Nolte HW, Noakes TD, Van Vuuren B: Trained humans can exercise safely in extreme dry heat when drinking water ad MK5108 manufacturer libitum. J Sports Sci 2011, 29:1233–1241.PubMedCrossRef 43. Nolte HW, Noakes TD, van Vuuren Ribonucleotide reductase B: Protection of total body water content and absence of hyperthermia despite 2% body mass loss (‘voluntary dehydration’) in soldiers drinking ad libitum during prolonged exercise in cool environmental conditions. Br J Sports Med 2011, 45:1106–1112.PubMedCrossRef 44. Lebus DK, Casazza GA, Hoffman MD, Van Loan MD: Can changes in body mass and total body water accurately predict hyponatremia after a 161-km find more running race? Clin J

Sport Med 2010, 20:193–199.PubMedCrossRef 45. Noakes T: Fluid replacement during marathon running. Clin J Sport Med 2003, 13:309–318.PubMedCrossRef 46. Lund-Johansen P, Stranden E, Helberg S, Wessel-Aas T, Risberg K, Rønnevik PK, Istad H, Madsbu S: Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine. J Hypertens 2003, 21:1003–1010.PubMedCrossRef 47. Ali A, Creasy RH, Edge JA: Physiological effects of wearing graduated compression stockings during running. Eur J Appl Physiol 2010, 109:1017–1025.PubMedCrossRef 48. Belcaro G, Cesarone MR, Shah SS, Nicolaides AN, Geroulakos G, Ippolito E, Winford M, Lennox A, Pellegrini L, Brandolini R, et al.: Prevention of edema, flight microangiopathy and venous thrombosis in long flights with elastic stockings. A randomized trial: The LONFLIT 4 Concorde Edema-SSL Study. Angiology 2002, 53:635–645.

Apex with or without papilla and with a pore-like ostiole. Peridium 2-layered. Hamathecium of dense, long cellular pseudoparaphyses, septate, embedded in mucilage. Asci bitunicate, fissitunicate, cylindrical to clavate, with a short, furcate pedicel. Ascospores ellipsoid, hyaline at first, turning brown at maturity, 1-septate, strongly JNK-IN-8 constricted at the septum. Anamorphs reported for genus: none. Literature: Yuan 1994. Type species Barria piceae Z.Q. Yuan, Mycotaxon 51: 314 (1994). (Fig. 10) Fig. 10 Barria piceae (from NY 92003, isotype). a Ascoma on the host surface. Note the wide opening ostiole. b Section of the partial peridium with two types

of cells. c, d Asci with ocular chambers and short pedicels. e, f Ellipsoid ascospores which are turning brown with thin sheath around them. Scale bars: a = 0.5 mm, b = 50 μm, c, d = 20 μm, e, f = 10 μm Ascomata 240–370 μm high × 200–320 μm diam., solitary, scattered, immersed, globose, subglobose, coriaceous, apex with or without papilla and with a pore-like click here ostiole (Fig. 10a). Peridium 20–35 μm thick, comprising two cell types, the outer cells comprising 3–4 layers of brown pseudoparenchymatous cells, cells 4–5 μm

diam., cell wall 2–3 μm thick, inner cells comprising 3–4 layers of pale brown compressed RGFP966 mouse cells, cells 2 × 16 μm diam., cell wall 0.5–1.5 μm thick (Fig. 10b). Hamathecium of dense, long cellular pseudoparaphyses, 2–3 μm broad, septate. Asci 135–200(−220) × 14–20 μm (\( \barx = 156 \times 16.6\mu m \), n = 10), 8-spored, bitunicate, fissitunicate, cylindrical to clavate, with a short, furcate pedicel, up to 22 μm long, with a large ocular chamber (ca. 4 μm wide × 3 μm high) (Fig. 10c and d). Ascospores 19–21.5 × 10–12 μm (\( \barx = 20.4 \times 11\mu m \), n = 10), uniseriate to partially overlapping, ellipsoid, hyaline or greenish with numerous small guttules at first and olive green to smoky

brown at maturity, 1-septate, strongly constricted at the septum, foveolate, surrounded with sheath (Fig. 10e and f). Anamorph: none reported. Material examined: CHINA, Xinjiang Province, Uygur, Dapagliflozin Urumqi, Tianshan Mountain, on needles of Picea schrenkiana, 1 Jul. 1992, Z.Q. Yuan (NY 92003, isotype). Notes Morphology Barria was established by Yuan (1994) as a monotypic genus represented by B. piceae according to its “two-celled, pigmented ascospores, pseudoparenchymatous peridium and narrowly cellular pseudoparaphyses” thus differing in its combination of characters from all of the morphologically related dothideomycetous genera, such as Didymosphaeria, Didymopleella or Stegasphaeria. The taxon was considered to belong in Phaeosphaeriaceae. Ascomata and colour or shape of ascospores, however, readily distinguish it from other 1-septate Phaeosphaeriaceae genera, i.e. Didymella, Lautitia and Metameris (Yuan 1994). Barria piceae causes blight of spruce needles. Phylogenetic study None.